Labor, Induced
35
6
7
21
Key Insights
Highlights
Success Rate
91% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
5.7%
2 terminated out of 35 trials
91.3%
+4.8% vs benchmark
20%
7 trials in Phase 3/4
33%
7 of 21 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 21 completed trials
Clinical Trials (35)
Comparison of Vaginal PGE2 (Dinoprostone) and Vaginal Misoprostol for Induction of Labour in Primigravid Term Pregnancy
Membrane Stripping for Cervical Ripening
PGE2 Followed by Oxytocin vs Oxytocin in Term PROM (POXY-PROM)
Use of Papaverine to Shorten the Second Stage/Duration of Labor in Pregnant Women After Cervical Ripening by Double-balloon Catheter
Maternal Informing on Labor Induction: Impact on Childbirth Experience
Topical Anesthesia During Catheter Insertion for Cervical Ripening (TOLERANCE)
Mifepristone Outpatient Labour Induction
Cervical Ripening Before Induction of Labour at Term: a Randomised Comparison of Prostin vs Propess
Impact of Timing of Neuraxial Analgesia on Obstetric, Anesthesiologic and Neonatal Outcomes in Induced Labour
Should I Have an Elective Induction?
Labor Induction With Oral Versus Vaginal Misoprostol
Effect of Acidic Vaginal pH on the Efficacy of Dinoprostone for Labor Induction
Misoprostol for Induction of Labor in Obese Women: Comparison Between 25 and 50 mcg Oral Administration
Comparing Outpatient to Inpatient Cervical Ripening Using Dilapan-S®
'Extended Balloon Catheter' Labour Induction; a Single Arm Pilot Trial'
Induction of Labour With a Double Balloon Catheter
Prediction of Spontaneous Onset of Labor at Term
Outpatient Labor Induction Using Oral Misoprostol in Norway
Labor Induction With a Combined Method (Pharmacologic and Mechanical): Randomized Controlled Trial
Oxytocin Dosage to Decrease Induction Duration